⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Immatics N.V. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Immatics N.V.
↗Tübingen, Germany
Immatics is a clinical-stage biopharmaceutical company dedicated to the development of T cell-redirecting immunotherapies for the treatment of cancer. The company focuses on precision oncology, specifically targeting PRAME, a protein expressed in over 50 types of cancer, using two primary modalities: Adoptive Cell Therapies (ACT) and antibody-like TCR Bispecifics (TCER™).
Headquartered in Tübingen, Germany, with significant operations in Stafford, Texas, Immatics leverages its proprietary XCEPTOR® platform for TCR discovery. The company maintains a robust clinical pipeline and strategic partnerships with global leaders to advance its mission of delivering transformative, life-changing therapies to patients with solid tumors.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Revenue:$100M-$200M
Founded:2000
Ownership:public
Status:operating
FUNDING
Total Raised:$236M
Investors:Amgen, Merifin Capital
STOCK
Exchange:NASDAQ
Ticker:IMTX
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 3 (Anzu-cel/IMA203)
Modalities:Cell therapy, TCR Bispecifics
Active Trials:4
Trial Phases:Phase 1: 2 | Phase 2: 1 | Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Immatics US, Inc.
Key Partnerships:Moderna (R&D collaboration), Editas Medicine (Gamma Delta T cell therapies), MD Anderson Cancer Center (Adoptive cellular therapies), Genmab (Bispecific immunotherapies), Bristol Myers Squibb, GlaxoSmithKline
COMPETITION
Position:Leader
Competitors:Cogent Biosciences, BeiGene, Regeneron Pharmaceuticals
LEADERSHIP
Key Executives:
Harpreet Singh - CEO
Peter Alan Chambré - Non-Executive Chairman
Scientific Founders:Hans-Georg Rammensee
Board Members:Heather L. Mason, Patrick Hwu
LINKS
Website:immatics.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Immatics N.V.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.